CancerIQ is the only cancer-focused precision health platform that empowers healthcare providers to detect cancer earlier and prevent it altogether across all patient populations. Integrated directly into real-time EHR workflows, CancerIQ makes it easy to gather comprehensive patient data, automatically map it to the latest evidence-based guidelines, and expand access to personalized care plans, cutting-edge clinical solutions, and genomic innovations.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/02/22 | $14,000,000 | Series B |
Amgen Business Development HealthX Ventures McKesson Ventures Merck Global Health Innovation Fund OSF Ventures | undisclosed |
